Dynavax Technologies



Ebit Zmiana Data
AbbVie USD 5.72B 69M 2025-06
Adma Biologics USD 37.59M 2.05M 2024-12
Amgen USD 2.26B 1.34B 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Biogen USD 816.6M 233.8M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Dynavax Technologies USD 10.86M 34.49M 2025-06
Gilead Sciences USD 2.7B 189M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Merck USD 6.36B 149M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Roche Holding CHF 11.29B 2.68B 2024-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
TG Therapeutics USD 34.84M 22.62M 2025-06
Vertex Pharmaceuticals USD 1.15B 420.8M 2025-06


Dynavax Technologies - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.